Riskpilot← Back to searchSign inGet full accessSveamedic AB
ABActiveOrg 5568185994Villa Vranäs, Vråkärr 362Medical specialists activities · NACE 8622Est. 20100 employees
Revenue 2024
SEK 883K
+101% vs 2023
EBITDA margin
96.1%
+122% vs 2023
Equity ratio
76.6%
Financial strength
Net profit 2024
SEK 509K
+123% vs 2023
| Revenue | SEK 883K | +101% |
| EBITDA | SEK 849K | +122% |
| Net profit | SEK 509K | +123% |
| Total assets | SEK 3,5M | +37% |
| Equity | SEK 2,7M | +20% |
| Employees | 0 | — |
Legal name
Sveamedic AB
Org number
5568185994
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 september 2010
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva medicinska tjänster samt köpa och sälja värdepapper samt därmed förenlig verksamhet.
Address
Villa Vranäs, Vråkärr 362
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 97 | 37 | 269 | 440 | 883 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 62 | 12 | 236 | 383 | 849 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 62 | 12 | 236 | 383 | 849 |
| Net financials | — | — | 0 | 6 | 6 |
| Profit before tax | 62 | 13 | 178 | 290 | 642 |
| Tax | −13 | −3 | −37 | −61 | −132 |
| Net profit | 49 | 10 | 142 | 229 | 509 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 195 | 2 171 | 2 201 | 2 550 | 3 506 |
| Equity | 1 857 | 1 866 | 2 008 | 2 237 | 2 686 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 338 | 305 | 135 | 156 | 449 |
| Total debt | 338 | 305 | 135 | 156 | 449 |
EBITDA margin
96.1%
This company
15.8%
Market median
+508% vs market
20202024
Equity ratio
76.6%
This company
38.2%
Market median
+101% vs market
20202024
Return on equity
19.0%
This company
18.4%
Market median
+3% vs market
20202024
Net profit margin
57.7%
This company
8.1%
Market median
+612% vs market
20202024
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EB Authorized Recipient of Service | Authorized Recipient of Service | 2018 |
| Former (2) | ||
ER Chief Auditor | Chief Auditor | 2018 – 2021 |
MJ Audit | Audit | 2011 – 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2011 | |
| Deputy Board Member | 2011 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sveamedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Beate Katrin Kühne Ottosson | Authorized Recipient of Service | 0 companies |
| Emma Rebecka Josefine Iderup | Chief Auditor | 0 companies |
| Mats Jörgen Wahlberg | Audit | 0 companies |
| Gisela Birgit Gie Vandehult | Board of Directors | 0 companies |
| Linnéa Hillevi Helena Ottosson | Deputy Board Member | 0 companies |
| Markus Orzol | Deputy Board Member | 0 companies |